Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: February 2013

7 - Sleep

from Section I - Structural and Functional Neuroanatomy

Related content

Powered by UNSILO


1. CirelliC, TononiG.Is sleep essential? PLoS Biol. 2008;6(8):e216.
2. RechtschaffenA, BergmannBM.Sleep deprivation in the rat: an update of the 1989 paper. Sleep 2002;25(1):18–24.
3. DawsonD, ReidK.Fatigue, alcohol and performance impairment. Nature 1997;388(6639):235.
4. LangeT, PerrasB, FehmHL, BornJ.Sleep enhances the human antibody response to hepatitis A vaccination. Psychosom Med. 2003;65(5):831–5.
5. Meier-EwertHK, RidkerPM, RifaiNet al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678–83.
6. SpiegelK, TasaliE, PenevP, Van CauterE.Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846–50.
7. SpiegelK, KnutsonK, LeproultR, TasaliE, Van CauterE.Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005;99(5):2008–19.
8. BorbelyAA, AchermannP.Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999;14(6):557–68.
9. IssaEB, WangX.Sensory responses during sleep in primate primary and secondary auditory cortex. J Neurosci. 2008;28(53):14,467–80.
10. Garcia-RillE.Disorders of the reticular activating system. Med Hypotheses 1997;49(5):379–87.
11. SaperCB, ScammellTE, LuJ.Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437(7063):1257–63.
12. SzymusiakR, McGintyD.Hypothalamic regulation of sleep and arousal. Ann N Y Acad Sci. 2008;1129:275–86.
13. StenbergD.Neuroanatomy and neurochemistry of sleep. Cell Mol Life Sci. 2007;64(10):1187–204.
14. HofmanMA, SwaabDF.The sexually dimorphic nucleus of the preoptic area in the human brain: a comparative morphometric study. J Anat. 1989;164:55–72.
15. GausSE, StreckerRE, TateBA, ParkerRA, SaperCB.Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 2002;115(1):285–94.
16. HametP, TremblayJ.Genetics of the sleep-wake cycle and its disorders. Metabolism 2006;55(10 Suppl 2):S7–12.
17. WulffK, PorcheretK, CussansE, FosterRG.Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. Curr Opin Genet Dev. 2009;19(3):237–46.
18. McCarleyRW.Mechanisms and models of REM sleep control. Arch Ital Biol. 2004;142(4):429–67.
19. LuJ, ShermanD, DevorM, SaperCB.A putative flip-flop switch for control of REM sleep. Nature 2006;441(7093):589–94.
20. HobsonJA, McCarleyRW.The brain as a dream state generator: an activation-synthesis hypothesis of the dream process. Am J Psychiatry 1977;134(12):1335–48.
21. HobsonA.A model for madness?Nature 2004;430(6995):21.
22. NelsonDE, TakahashiJS.Integration and saturation within the circadian photic entrainment pathway of hamsters. Am J Physiol. 1999;277(5 Pt 2):R1351–61.
23. LockleySW, EvansEE, ScheerFAet al. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006;29(2):161–8.
24. CirelliC.The genetic and molecular regulation of sleep: from fruit flies to humans. Nat Rev Neurosci. 2009;10(8):549–60.
25. FrankenP, DijkDJ.Circadian clock genes and sleep homeostasis. Eur J Neurosci. 2009;29(9):1820–9.
26. RechtschaffenA, KalesA (editors). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: U.S. National Institutes of Health, U. S. National Institute of Neurological Diseases and Blindness, Neurological Information Network; 1968.
27. IberC.The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
28. SteriadeM, AmzicaF.Sleep oscillations developing into seizures in corticothalamic systems. Epilepsia 2003;44 (Suppl. 12):9–20.
29. UrakamiY.Relationships between sleep spindles and activities of cerebral cortex as determined by simultaneous EEG and MEG recording. J Clin Neurophysiol. 2008;25(1):13–24.
30. BodizsR, KormendiJ, RigoP, LazarAS.The individual adjustment method of sleep spindle analysis: methodological improvements and roots in the fingerprint paradigm. J Neurosci Methods 2009;178(1):205–13.
31. TamakiM, MatsuokaT, NittonoH, HoriT.Activation of fast sleep spindles at the premotor cortex and parietal areas contributes to motor learning: a study using sLORETA. Clin Neurophysiol. 2009;120(5):878–86.
32. DijkDJ.Regulation and functional correlates of slow wave sleep. J Clin Sleep Med. 2009;5(2 Suppl):S6–15.
33. BjornessTE, KellyCL, GaoT, PoffenbergerV, GreeneRW.Control and function of the homeostatic sleep response by adenosine A1 receptors. J Neurosci. 2009;29(5):1267–76.
34. TerzanoMG, ParrinoL, SherieriAet al. Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med. 2001;2(6):537–53.
35. TerzanoMG, ParrinoL, SmerieriA.[Neurophysiological basis of insomnia: role of cyclic alternating patterns]. Rev Neurol. (Paris) 2001;157(11 Pt 2):S62–6.
36. FerriR, HuberR, AricoDet al. The slow-wave components of the cyclic alternating pattern (CAP) have a role in sleep-related learning processes. Neurosci Lett. 2008;432(3):228–31.
37. BruniO, FerriR, VittoriEet al. Sleep architecture and NREM alterations in children and adolescents with Asperger syndrome. Sleep 2007;30(11):1577–85.
38. GuilleminaultC, PoyaresD, RosaAet al. Chronic fatigue, unrefreshing sleep and nocturnal polysomnography. Sleep Med. 2006;7(6):513–20.
39. LopesMC, Quera-SalvaMA, GuilleminaultC.Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine). Sleep Med. 2007;9(1):33–41.
40. SteriadeM.Grouping of brain rhythms in corticothalamic systems. Neuroscience 2006;137(4):1087–106.
41. RectorDM, ScheiJL, Van DongenHP, BelenkyG, KruegerJM.Physiological markers of local sleep. Eur J Neurosci. 2009;29(9):1771–8.
42. KruegerJM, RectorDM, RoySet al. Sleep as a fundamental property of neuronal assemblies. Nat Rev Neurosci. 2008;9(12):910–19.
43. HeraghtyJL, HilliardTN, HendersonAJ, FlemingPJ.The physiology of sleep in infants. Arch Dis Child. 2008;93(11):982–5.
44. FeinbergI, HigginsLM, KhawWY, CampbellIG.The adolescent decline of NREM delta, an indicator of brain maturation, is linked to age and sex but not to pubertal stage. Am J Physiol Regul Integr Comp Physiol. 2006;291(6):R1724–9.
45. HuberR, GhilardiMF, MassiminiM, TononiG.Local sleep and learning. Nature 2004;430(6995):78–81.
46. WeinertD.Age-dependent changes of the circadian system. Chronobiol Int. 2000;17(3):261–83.
47. DuffyJF, ZeitzerJM, CzeislerCA.Decreased sensitivity to phase-delaying effects of moderate intensity light in older subjects. Neurobiol Aging 2007;28(5):799–807.
48. HaimovI, LavieP, LaudonMet al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18(7):598–603.
49. NaidooN, FerberM, MasterM, ZhuY, PackAI.Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci. 2008;28(26):6539–48.
50. KrystalAD.Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med. 2007;3(1):63–72.
51. ArmitageR, LandisC, HoffmannRet al. The impact of a 4-hour sleep delay on slow wave activity in twins discordant for chronic fatigue syndrome. Sleep 2007;30(5):657–62.
52. BeltNK, KronholmE, KauppiMJ.Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol. 2009;27(1):35–41.
53. DaviesKA, MacfarlaneGJ, NichollBIet al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford) 2008;47(12):1809–13.
54. McKeithIG.Clinical Lewy body syndromes. Ann N Y Acad Sci. 2000;920:1–8.
55. HarperDG, StopaEG, McKeeACet al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 2001;58(4):353–60.
56. KlaffkeS, StaedtJ.Sundowning and circadian rhythm disorders in dementia. Acta Neurol Belg. 2006;106(4):168–75.
57. BenedettiF, CalabreseG, BernasconiAet al. Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. Psychiatry Res. 2009;173(3):238–42.
58. Wirz-JusticeA, BenedettiF, BergerMet al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 2005;35(7):939–44.
59. FerrarelliF, HuberR, PetersonMJet al. Reduced sleep spindle activity in schizophrenia patients. Am J Psychiatry 2007;164(3):483–92.
60. SackRL, AuckleyD, AugerRRet al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 2007;30(11):1484–501.
61. WinkelmannJ, PoloO, ProviniFet al. Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord. 2007;22(Suppl. 18):S449–58.
62. OndoWG.Restless legs syndrome. Neurol Clin. 2009;27(3):779–99, vii.
63. Bara-JimenezW, AksuM, GrahamB, SatoS, HallettM.Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000;54(8):1609–16.
64. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd edition. Westchester, IL: American Academy of Sleep Medicine; 2005.
65. KrystalAD, EdingerJD, WohlgemuthWK, MarshGR.NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 2002;25(6):630–40.
66. EdingerJD, KrystalAD.Subtyping primary insomnia: is sleep state misperception a distinct clinical entity? Sleep Med Rev. 2003;7(3):203–14.
67. BonnetMH, ArandDL.24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18(7):581–8.
68. PerlisML, KehrEL, SmithMTet al. Temporal and stagewise distribution of high frequency EEG activity in patients with primary and secondary insomnia and in good sleeper controls. J Sleep Res. 2001;10(2):93–104.
69. MericaH, BloisR, GaillardJM.Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci. 1998;10(5):1826–34.
70. BastienCH, St-JeanG, MorinCM, TurcotteI, CarrierJ.Chronic psychophysiological insomnia: hyperarousal and/or inhibition deficits? An ERPs investigation. Sleep 2008;31(6):887–98.
71. VgontzasAN, BixlerEO, LinHMet al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86(8):3787–94.
72. VgontzasAN, ChrousosGP.Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am. 2002;31(1):15–36.
73. NofzingerEA, BuysseDJ, GermainAet al. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004;161(11):2126–8.
74. CortoosA, VerstraetenE, CluydtsR.Neurophysiological aspects of primary insomnia: implications for its treatment. Sleep Med Rev. 2006;10(4):255–66.
75. EdingerJD, MeansMK.Cognitive-behavioral therapy for primary insomnia. Clin Psychol Rev. 2005;25(5):539–58.
76. MorinCM, BootzinRR, BuysseDJet al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep 2006;29(11):1398–414.
77. RybarczykB, StepanskiE, FoggLet al. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol. 2005;73(6):1164–74.
78. SivertsenB, NordhusIH.Management of insomnia in older adults. Br J Psychiatry 2007;190:285–6.
79. WalshJK, PerlisM, RosenthalMet al. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia. J Clin Sleep Med. 2006;2(1):35–41.
80. WalshJK, DeaconS, DijkDJ, LundahlJ.The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. Sleep 2007;30(5):593–602.
81. GoforthHW.Low-dose doxepin for the treatment of insomnia: emerging data. Expert Opin Pharmacother. 2009;10(10):1649–55.
82. EstivillE, LegerD, SoubraneC.A randomized double-blind placebo-controlled 12-week trial of eplivanserin with long-term open extension in insomniac patients with sleep maintenance difficulties: results from the double-blind treatment period. Sleep 2009;32:A41-A.
83. DingemanseJ, DorffnerG, GoranHet al. Proof-of-concept study in primary insomnia patients with ACT-078573, a dual orexin receptor antagonist. Sleep Biol Rhythms 2007;5(Suppl 1; Late breaking abstracts):A194.
84. MondererR, ThorpyM.Sleep disorders and daytime sleepiness in Parkinson's disease. Curr Neurol Neurosci Rep. 2009;9(2):173–80.
85. KapsimalisF, BastaM, VarouchakisGet al. Cytokines and pathological sleep. Sleep Med. 2008;9(6):603–14.
86. KanbayashiT, KodamaT, KondoHet al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009;32(2):181–7.
87. NishinoS, KanbayashiT.Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310.
88. KhatamiR, MaretS, WerthEet al. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet 2004;363(9416):1199–200.
89. NishinoS, OkuroM, KotoriiNet al. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol. (Oxford) 2010;198(3):209–22.
90. BlackJE, BrooksSN, NishinoS.Conditions of primary excessive daytime sleepiness. Neurol Clin. 2005;23(4):1025–44.
91. MignotE, NishinoS.Emerging therapies in narcolepsy-cataplexy. Sleep 2005;28(6):754–63.
92. ArnulfI, ZeitzerJM, FileJ, FarberN, MignotE.Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain 2005;128(Pt 12):2763–76.
93. HuangYS, GuilleminaultC, KaoPF, LiuFY.SPECT findings in the Kleine–Levin syndrome. Sleep 2005;28(8):955–60.
94. DauvilliersY, MayerG, LecendreuxMet al. Kleine–Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology 2002;59(11):1739–45.
95. HuangYS, LinYH, GuilleminaultC.Polysomnography in Kleine–Levin syndrome. Neurology 2008;70(10):795–801.
96. KoerberRK, TorkelsonR, HavenGet al. Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine–Levin syndrome. Neurology 1984;34(12):1597–600.
97. DauvilliersY, BaumannCR, CarlanderBet al. CSF hypocretin-1 levels in narcolepsy, Kleine–Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74(12):1667–73.
98. PoppeM, FriebelD, ReunerUet al. The Kleine–Levin syndrome – effects of treatment with lithium. Neuropediatrics 2003;34(3):113–19.
99. BroughtonRJ.Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in “dreaming sleep”. Science 1968;159(819):1070–8.
100. MahowaldMW, SchenckCH.Non-rapid eye movement sleep parasomnias. Neurol Clin. 2005;23(4):1077–106, vii.
101. GrillnerS.The motor infrastructure: from ion channels to neuronal networks. Nat Rev Neurosci. 2003;4(7):573–86.
102. TassinariCA, RubboliG, GardellaEet al. Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci. 2005;26(Suppl. 3):s225–32.
103. MasonTB, 2nd, PackAI.Pediatric parasomnias. Sleep 2007;30(2):141–51.
104. StunkardAJ, GraceWJ, WolffHG.The night eating syndrome; a pattern of food intake among certain obese patients. Am J Med. 1955;19(1):78–86.
105. HowellMJ, SchenckCH, CrowSJ.A review of nighttime eating disorders. Sleep Med Rev. 2009;13(1):23–34.
106. O’ReardonJP, StunkardAJ, AllisonKC.Clinical trial of sertraline in the treatment of night eating syndrome. Int J Eat Disord. 2004;35(1):16–26.
107. AgargunMY, GulecM, CilliASet al. Nightmares and serum cholesterol level: a preliminary report. Can J Psychiatry 2005;50(6):361–4.
108. DierksMR, JordanJK, SheehanAH.Prazosin treatment of nightmares related to posttraumatic stress disorder. Ann Pharmacother. 2007;41(6):1013–17.
109. AalbersbergCF, MulderJM.[Topiramate for the treatment of post traumatic stress disorder. A case study]. Tijdschr Psychiatr. 2006;48(6):487–91.
110. DavisJL, WrightDC.Randomized clinical trial for treatment of chronic nightmares in trauma-exposed adults. J Trauma Stress 2007;20(2):123–33.
111. KrakowB, HollifieldM, JohnstonLet al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. J Am Med Assoc 2001;286(5):537–45.
112. MooreBA, KrakowB.Imagery rehearsal therapy for acute posttraumatic nightmares among combat soldiers in Iraq. Am J Psychiatry 2007;164(4):683–4.
113. BoeveBF, SilberMH, SaperCBet al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130(Pt 11):2770–88.
114. PostumaRB, GagnonJF, VendetteMet al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009;72(15):1296–300.